Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas

Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pancreas

NCT00038701 ·Status: TERMINATED ·Phase: PHASE2

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

NCT02336087 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy

NCT01938716 ·Status: TERMINATED ·Phase: NA

A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma

NCT05494866 ·Status: TERMINATED ·Phase: PHASE1

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

NCT01234935 ·Status: COMPLETED ·Phase: PHASE2

Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint

NCT00613730 ·Status: TERMINATED ·Phase: PHASE2

Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer

NCT00316420 ·Status: COMPLETED ·Phase: PHASE1

A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients

NCT00907166 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Adavosertib and Gemcitabine in Advanced Pancreatic

NCT05212025 ·Status: WITHDRAWN ·Phase: PHASE2

Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

NCT00004884 ·Status: COMPLETED ·Phase: PHASE2

Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer

NCT01893294 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma

NCT01108458 ·Status: TERMINATED ·Phase: PHASE2

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer

NCT00004861 ·Status: COMPLETED ·Phase: PHASE2

Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer

NCT00529113 ·Status: TERMINATED ·Phase: PHASE1

Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA

NCT01893801 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Gemcitabine and CT-011 for Resected Pancreatic Cancer

NCT01313416 ·Status: TERMINATED ·Phase: PHASE2

Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients

NCT02732938 ·Status: TERMINATED ·Phase: PHASE2

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

NCT00068432 ·Status: COMPLETED ·Phase: PHASE2

Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer

NCT00202800 ·Status: COMPLETED ·Phase: PHASE2

EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas

NCT00377936 ·Status: COMPLETED ·Phase: PHASE2

Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer

NCT02047500 ·Status: TERMINATED ·Phase: PHASE1

Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma

NCT02391662 ·Status: COMPLETED ·Phase: PHASE2

PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer

NCT01839487 ·Status: COMPLETED ·Phase: PHASE2

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

NCT04115163 ·Status: RECRUITING ·Phase: PHASE2

Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer

NCT03520790 ·Status: TERMINATED ·Phase: PHASE1